Friday, March 17, 2023
Image
Thermo Fisher Scientific’s PPD clinical research business, which is based in Wilmington, was awarded a five-year contract to provide regulatory affairs support and related services for the NIH’s Blueprint MedTech program. The new program will support development of translational neurological devices.